The Global Pharmaceutical Gelatin Market will Hit $1.6 Billion by 2028, at a CAGR of 5.5%

Pharmaceutical Gelatin Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Pharmaceutical Gelatin Market size is expected to reach $1.6 billion by 2028, rising at a market growth of 5.5% CAGR during the forecast period.

The Type B market acquired maximum revenue share in the Global Pharmaceutical Gelatin Market by Type in 2021; thereby, achieving a market value of $1.0 billion by 2028. The growth is owing to numerous factors like low production cost because of the more accessible and broader availability of the raw material and its application in the pharmaceutical industry. Gelatin B is derived from beef skin.

The Bovine Skin market is showcasing a CAGR of 5.7% during (2022 - 2028). This is due to bovine gelatin being a colorless, flavorless, translucent, and brittle food additive derived from collagen present in the skin of animals. The usage of bovine gelatin has increased due to the rising awareness of health among the population.

The Stabilizing Agent market is leading the segment in the Global Pharmaceutical Gelatin Market by Function in 2021; thereby, achieving a market value of $873.9 million by 2028. This is because of the usage of specially purified gelatin, with low endotoxin levels, as a stabilizer in some vaccines. It also has various other benefits, like keeping lyophilized (freeze-dried) products stable, reducing the potential for side effects, and ensuring patient safety.

The Softgel Capsules market is exhibiting a CAGR of 5.8% during (2022 - 2028). In comparison to hard capsules, the soft gel capsules are thicker and need ingredients like glycerin to get soft texture. The market is expanding in this segment as these types of capsules are easy to swallow and are more preferred by consumers.

The North America market dominated the Global Pharmaceutical Gelatin Market by Region in 2021; thereby, achieving a market value of $548.3 million by 2028. The Asia Pacific market is poised to grow at a CAGR of 6.2% during (2022 - 2028). Additionally, The Europe market would witness a CAGR of 5.1% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/pharmaceutical-gelatin-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.

Global Pharmaceutical Gelatin Market Segmentation

By Type

• Type B
• Type A

By Source

• Porcine
• Bovine Skin
• Bovine Bone
• Marine
• Poultry

By Function

• Stabilizing Agent
• Thickening Agent
• Gelling Agent & Others

By Application

• Hard Capsules
• Softgel Capsules
• Tablets
• Absorbable Hemostats
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • Egypt
  • Tanzania
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Darling Ingredients, Inc.
• Nitta Gelatin, Inc.
• Tessenderlo Group nv
• Gelita AG
• SAS Gelatines Weishardt
• Lonza Group Ltd. (Capsugel)
• Norland Products, Inc.
• Roxlor Group
• Catalent, Inc.

Related Reports:

North America Pharmaceutical Gelatin Market Size to 2028

• December-2022
• 79 Pages

LAMEA Pharmaceutical Gelatin Market Size & Share by 2028

• December-2022
• 94 Pages

Europe Pharmaceutical Gelatin Market Size & Growth to 2028

• December-2022
• 93 Pages

Asia Pacific Pharmaceutical Gelatin Market Size & Share, 2028

• December-2022
• 94 Pages